High prevalence of ceftriaxone-resistant and XDR <i>Neisseria gonorrhoeae</i> in several cities of Cambodia, 2022–23: WHO Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP)

Abstract

A high prevalence of ceftriaxone-resistant, MDR and XDR <i>N. gonorrhoeae</i> in several cities of Cambodia were found during 2022-23 in WHO EGASP. This necessitates expanded <i>N. gonorrhoeae</i> AMR surveillance, revision of the nationally recommended gonorrhoea treatment, mandatory test of cure, enhanced sexual contact notification, and ultimately novel antimicrobials for the treatment of gonorrhoea.